Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Bristol Medical School: The first trial to investigate The Lightning Process®(LP) published in the Archives of Disease in Childhood

BRISTOL, 21-Sep-2017 — /EuropaWire/ — The first trial to investigate The Lightning Process® (LP) is published today [Thursday 21 September] in the Archives of Disease in Childhood. In this trial, the effectiveness of LP in addition to specialist medical care was … Read the full press release

Sanofi Genzyme, Alnylam Pharmaceuticals: APOLLO Phase 3 study of patisiran met its primary efficacy endpoint and all secondary endpoints

Investigational RNAi Therapeutic Patisiran Meets Primary and All Secondary Endpoints, with Highly Significant Reduction In Neuropathy Progression and Improvement in Quality of Life at 18 Months Relative to Placebo Alnylam Intends to File New Drug Application (NDA) in Late 2017 … Read the full press release

Umeå University: membrane-derived vesicles (MVs) from Vibrio cholerae and Listeria monocytogenes transport pore-forming toxins (PFTs)

Umeå, Sweden, 21-Sep-2017 — /EuropaWire/ — Bacteria release membrane-derived vesicles (MVs), which are small particles that can transport virulence factors to neighbouring bacteria or to the cells of a mammalian host. This special MV-based system for delivering toxic proteins and nucleic … Read the full press release

University of Dundee: Smoking and diabetes are leading risk factors for peripheral artery disease (PAD)

research also points to diabetes as cause of disease that can lead to limb amputation DUNDEE, 20-Sep-2017 — /EuropaWire/ — Smoking and diabetes are the two leading risk factors for peripheral artery disease (PAD), a narrowing of the arteries which can … Read the full press release

Philips will showcase its wide portfolio of OB/GYN ultrasound tools at 27th World Congress on Ultrasound in Obstetrics and Gynecology (ISUOG)

Company expands offering in Obstetrics and Gynecology Ultrasound (OB/GYN) with innovations that are designed to support earlier, easier and more confident diagnosis New anatomical intelligence, fingertip control and enhanced imaging versatility features for Philips’ EPIQ and Affiniti ultrasound systems offer … Read the full press release

Philips to improve the lives of 300 million people a year by 2025

Philips makes extended commitment to improve the lives of 300 million people in underserved healthcare communities by 2025 Amsterdam, the Netherlands  and New York, U.S.A., 19-Sep-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is … Read the full press release

Merck: Grant for Growth Innovation (GGI) for 2017 winners announced in Washington, U.S.

Not intended for US/Canada based media The presentation of the grants coincides with the 10th International Meeting of Pediatric Endocrinology The awards program supports advancements in the field of growth and growth disorders DARMSTADT, 19-Sep-2017 — /EuropaWire/ — Merck, a leading … Read the full press release

GSK: US FDA VRBPAC’s vote brings us one step closer to approval of Shingrix

LONDON, 14-Sep-2017 — /EuropaWire/ — GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support the efficacy and safety of Shingrix … Read the full press release

Roche study combining Esbriet and nintedanib treatment: majority of the patients tolerated the combination treatment

New study combining Esbriet (pirfenidone) and nintedanib showing similar safety profile for the combination treatment to that expected for each treatment alone A second, retrospective, post-hoc, analysis suggests that treatment with Esbriet may be associated with a reduction of multiple … Read the full press release

Roche phase III BRIM8 study: 46% reduction in recurrence risk was observed in stage IIC-IIIB melanoma patients

BASEL, 14-Sep-2017 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced data for the phase III BRIM8 study, which was designed to investigate the efficacy and safety of Zelboraf® (vemurafenib) in the adjuvant (after surgery) treatment of people with … Read the full press release

UK Gov: National Health Service (NHS) and Public Health England (PHE) announce new plan to save thousands of people from heart attacks and strokes

NHS and PHE launch new drive to save thousands of people from heart attacks and strokes. LONDON, 12-Sep-2017 — /EuropaWire/ — The NHS and Public Health England (PHE) will today (Tuesday, 12 September 2017) announce a new drive to save thousands of … Read the full press release

AstraZeneca Phase III PACIFIC trial: Imfinzi demonstrated statistically-significant and clinically-meaningful improvement in PFS

Imfinzi improves progression-free survival (PFS) by more than 11 months compared to standard of care and is the first medicine to show superior PFS in this setting Data presented at the ESMO 2017 Congress follows FDA’s recent Breakthrough Therapy Designation … Read the full press release

AstraZeneca Phase III FLAURA trial supports Tagrisso’s potential as a new standard of care in 1st-line EGFR-mutated lung cancer

Phase III FLAURA trial results show Tagrisso reduced the risk of progression or death by more than half, with consistent benefit across all subgroups, including patients with and without brain metastases Unprecedented median progression-free survival (PFS) of 18.9 months compared … Read the full press release

High blood pressure: Medtronic to move forward with a new renal denervation pivotal trial

Published Simultaneously in The Lancet, the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA, 04-Sep-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced its intent … Read the full press release

EMBO: new TREM2 research suggests a new therapeutic target in Alzheimer’s disease treatment

Uncovering the molecular mechanism behind a rare genetic risk factor of Alzheimer’s disease points to a new therapeutic target HEIDELBERG, 04-Sep-2017 — /EuropaWire/ — A gene called triggering receptor expressed on myeloid cells 2, or TREM2, has been associated with numerous … Read the full press release

Shire MYDAYIS now available by prescription in the United States

Mydayis, which is now available in the U.S., demonstrated improvements lasting up to 16 hours post-dose, beginning at 2 or 4 hours post-dose, compared to placebo, in total score on a skill-adjusted math test that measures attention in ADHD Lexington, … Read the full press release

Deutsche Telekom to introduce world’s first Virtual Reality (VR) game that helps scientists fight dementia

First consumer VR game where players can help to advance dementia research through gameplay Building on the success of the mobile game Sea Hero Quest, which collected the data of almost 3 million players worldwide VR game allows for more … Read the full press release

Novartis: ACZ885 led to 15% reduction in the risk of major adverse cardiovascular events (MACE) compared to placebo

Study showed a significant 15% reduction of major adverse cardiovascular events (MACE) in people with a prior heart attack and inflammatory atherosclerosis who were treated with 150mg of ACZ885, in addition to standard of care including lipid-lowering therapy Effect driven … Read the full press release

Novartis: ACZ885 reduced the rate of lung cancer incidence and mortality among study participants

Review of blinded, pre-planned oncology safety analyses revealed a 77% reduction in lung cancer mortality and 67% reduction in lung cancer cases in patients treated with 300mg of ACZ885 CANTOS is the first Phase III clinical trial to support a … Read the full press release

Philips: Egbert van Acht to succeed Pieter Nota as Chief Business Leader, Personal Health businesses

AMSTERDAM, 28-Aug-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG; AEX: PHIA) today announced that Egbert van Acht, who currently leads Philips’ Health & Wellness business group, will succeed Pieter Nota as Chief Business Leader of Philips’ Personal Health businesses, effective October 1, … Read the full press release

Invacare introduce their first touch screen remote

BASEL, Switzerland, 23-Aug-2017 — /EuropaWire/ — Global brand leader Invacare brings next generation technology to powerchairs, following extensive trials and consumer-led insights. Touch screen technology is used daily on devices such as smartphones and tablets and thanks to Invacare, this … Read the full press release

3,930 total views, 2 views today

UK: Competition and Markets Authority found competition concerns in the merger between Cygnet and Cambian Adult Services

The CMA has provisionally found competition concerns in the merger between Cygnet and the Cambian Adult Services division of the Cambian Group. LONDON, 23-Aug-2017 — /EuropaWire/ — Universal Health Services, Inc. – through its subsidiary Cygnet Health Care Limited (Cygnet) – acquired … Read the full press release

SGS: European Commission to restrict the application of zinc oxide as a colorant starting from August 24, 2017

The European Commission has published Regulation (EU) 2017/1413 to restrict the application of zinc oxide (CAS No. 1314-13-2) as a colorant. GENEVA, 22-Aug-2017 — /EuropaWire/ — Zinc oxide is a permitted colorant, in Entry 144 of Annex IV to Regulation (EC) … Read the full press release

Invacare International take powerchairs to a new level

CARDIFF, 18-Aug-2017 — /EuropaWire/ — Global brand leader Invacare is once again raising the bar in the powerchair market, following on from the successful launch of the LiNX control system last year. Invacare has taken the smart technology a step … Read the full press release

714 total views, 3 views today

Medtronic: global randomized clinical trial to evaluate one-month dual antiplatelet therapy (DAPT) in patients with the Resolute Onyx(TM) DES during percutaneous coronary intervention (PCI)

First-of-its-Kind Randomized Clinical Trial Will Evaluate One-Month DAPT in Patients Following PCI Procedures with the Newer-Generation Durable Polymer Resolute Onyx DES DUBLIN, 18-Aug-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced a global randomized clinical trial that will evaluate one-month … Read the full press release

Shire submits MAA for lifitegrast: If approved it will address the signs and symptoms of dry eye disease in adults in Europe

Lifitegrast, if approved, would be the first and only new class treatment to address the signs and symptoms of dry eye disease in adults in Europe ZUG, 16-Aug-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the Marketing Authorization … Read the full press release

Destatis: settlement with statutory health insurance institutions accounted for 70.4% of the receipts of medical practices in 2015

WIESBADEN, 16-Aug-2017 — /EuropaWire/ — In 2015, settlement with statutory health insurance institutions accounted for the largest part of the receipts of medical practices (70.4%). The Federal Statistical Office (Destatis) also reports that 26.3% of the receipts came from settlement with … Read the full press release

Destatis: 19,5 Millionen Patienten im Jahr 2016 stationär im Krankenhaus behandelt

WIESBADEN, 15-Aug-2017 — /EuropaWire/ — Im Jahr 2016 wurden 19,5 Millionen Patientinnen und Patienten stationär im Krankenhaus behandelt. Das waren 277 400 Behandlungsfälle oder 1,4 % mehr als im Jahr zuvor. Wie das Statistische Bundesamt (Destatis) nach vorläufigen Ergebnissen weiter mitteilt, dauerte der … Read the full press release

University of Southampton: new experimental drug in certain patients with diffuse large B-cell lymphoma

SOUTHAMPTON, 14-Aug-2017 — /EuropaWire/ — Patients with a common type of fast-growing cancer are being given fresh hope in a new clinical trial. Scientists at the University of Southampton are, for the first time, to trial a new experimental drug, in … Read the full press release

University of Helsinki: neuroprotective protein CDNF entered clinical trials on Parkinson’s disease patients

HELSINKI, 14-Aug-2017 — /EuropaWire/ — With the help of the two-year Therapeutic Idea Award from the US Department of Defense professor Saarma and Dr. Voutilainen aim to generate more preclinical data i.e. data from tests preceding the patient trials, to support … Read the full press release